Network origin in Klaus K. Wilgenbus first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
RWTH Aachen University
61
| College/University | Other Consumer Services | 61 |
| Public Company | Financial Conglomerates | 18 | |
| Public Company | Data Processing Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Klaus K. Wilgenbus via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| EON SE | Electric Utilities | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BMW AG | Motor Vehicles | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| LECHWERKE AG | Electric Utilities | Chairman Director/Board Member | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Chairman Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Essent N.V.
 Essent N.V. Electric UtilitiesUtilities Essent NV engages in the supply of electricity, gas, and heat to consumers and corporations. It offers electricity generated through biomass, wind energy, combined heat and power plants. The company was founded in 1999 and is headquartered in ’s-Hertogenbosch, the Netherlands. | Electric Utilities | Director/Board Member Chairman | |
SCHOTT AG
 SCHOTT AG Home FurnishingsConsumer Durables SCHOTT AG engages in the production and distribution of specialty glass and glass ceramics. Its products are used in the consumer electronics, pharmaceutical, defense and security, optics, life sciences, energy and environment, automotive, and aviation industries. The company was founded by Otto Schott, Ernst Abbe, Carl Zeiss and Roderich Zeiss in 1884 and is headquartered in Mainz, Germany. | Home Furnishings | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| ENBW ENERGIE BADEN-WÜRTTEMBERG AG | Electric Utilities | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ZF Friedrichshafen AG
 ZF Friedrichshafen AG Auto Parts: OEMProducer Manufacturing ZF Friedrichshafen AG provides driveline and chassis as well as active and passive safety technology solutions. The company was founded on August 20, 1915 by Alfred Count von Soden-Fraunhofen and Alfred Colsman and is headquartered in Friedrichshafen, Germany. | Auto Parts: OEM | Director/Board Member Corporate Officer/Principal | |
Stadtwerke Düsseldorf AG
 Stadtwerke Düsseldorf AG Electric UtilitiesUtilities Stadtwerke Düsseldorf AG engages in the distribution of electricity, natural gas, water, as well as district and local heating to private and corporate clients. It also provides waste incineration services. The company was founded in 1866 and is headquartered in Duesseldorf, Germany. | Electric Utilities | Chairman Director/Board Member | |
| OREXO AB | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| Stockholm School of Economics | College/University | Undergraduate Degree Undergraduate Degree | |
| Technische Universität München | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Chairman Director of Finance/CFO Chief Executive Officer | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| XINYU IRON & STEEL CO., LTD | Steel | Director/Board Member Director/Board Member | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| NET MOBILE AG | Specialty Telecommunications | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| University of Hamburg | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| Henley Management College | College/University | Masters Business Admin Masters Business Admin | |
Prinovis GmbH & Co. KG
 Prinovis GmbH & Co. KG Commercial Printing/FormsCommercial Services Prinovis GmbH & Co. KG provides gravure printing and custom made printing services. It offers a portfolio of solutions – from the conceptual work, via gravure printing and web offset printing, right through to product binding and logistics. The company is headquartered in Hamburg, Germany. | Commercial Printing/Forms | Chairman Chief Executive Officer | |
| University of Science & Technology Beijing | College/University | Corporate Officer/Principal Undergraduate Degree | |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
The Chinese Society for Metals
 The Chinese Society for Metals Miscellaneous Commercial ServicesCommercial Services The Chinese Society for Metals is a national, academic, popular science, and non-profit social organization that focuses on metallurgy and material science and technology. The company was founded on November 26, 1956 and is headquartered in Beijing, China. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Forschungszentrum Jülich GmbH
 Forschungszentrum Jülich GmbH Miscellaneous Commercial ServicesCommercial Services Forschungszentrum Jülich GmbH is a research center located in Julich, Germany. The Institute for Advanced Simulation is one of the German company's main focuses, which combines simulation sciences and expertise to tackle upcoming challenges in the field. The private company also collaborates with various universities and research institutions worldwide to advance their research. Additionally, the company is involved in the European IAGOS project, which observes the composition of the atmosphere using commercial passenger planes as measurement platforms. The company's vision is to understand the human brain through simulation, as demonstrated in the "Human Brain Project." The company was founded in 1956 and is currently led by CEOs Wolfgang Marquardt, Pieter Jansens, and Astrid Lambrecht. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
E.ON Kundsupport Sverige AB
 E.ON Kundsupport Sverige AB Miscellaneous Commercial ServicesCommercial Services Part of E.ON SE, E.ON Kundsupport Sverige AB engages in the operation of a call center. The company is based in Malmö, Sweden. Leonhard Birnbaum has been the CEO of the Swedish company since 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Technische Universität Hamburg-Harburg | College/University | Corporate Officer/Principal Doctorate Degree | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Apleona GmbH
 Apleona GmbH Miscellaneous Commercial ServicesCommercial Services Apleona GmbH engages in the provision of real estate and facility management services. It operates through the following business areas: Facility Management, Real Estate Management, Building Technology, and Interior Fitouts. The firm offers services such as integrated facility management, facility management consulting, fund and asset management, leasehold improvements, drywall construction solutions, turnkey interior fittings and modernization, as well as fabrication and assembly of own fitting systems. The company is headquartered in Neu-Isenburg, Germany. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Arctic Asset Management AS (Sweden)
 Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients. | Investment Managers | Founder Chief Executive Officer | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Founder | |
Amprion GmbH
 Amprion GmbH Electric UtilitiesUtilities Amprion GmbH engages in operation of a transmission system in Germany and Europe. It distributes and generates electricity. The firm also provides information technology (IT) outsourcing services. The company was founded in 2003 and is headquartered in Dortmund, Germany. | Electric Utilities | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistics
International
| Sweden | 24 |
| Germany | 18 |
| Denmark | 4 |
| China | 4 |
| Netherlands | 2 |
Sectoral
| Health Technology | 16 |
| Commercial Services | 10 |
| Consumer Services | 9 |
| Utilities | 8 |
| Finance | 6 |
Operational
| Director/Board Member | 356 |
| Corporate Officer/Principal | 165 |
| Chairman | 133 |
| Chief Executive Officer | 119 |
| Independent Dir/Board Member | 58 |
Most connected contacts
| Insiders | |
|---|---|
| Rolf Buch | 53 |
| Rolf Martin Schmitz | 40 |
| Peter Sjöstrand | 35 |
| Bo Jesper Hansen | 34 |
| Michael Wilhelm Rosenlew | 32 |
| Torbjørn Bjerke | 27 |
| Willi Mannheims | 27 |
| Franz Richter | 24 |
| Kristian Schleede | 23 |
| Karsten Wildberger | 23 |
| Gunilla Anders Ekström | 22 |
| Henrijette Richter | 21 |
| Carl Johan Bertil Sundberg | 21 |
| Gerhard Fettweis | 20 |
| Christoph Schmallenbach | 19 |
- Stock Market
- Insiders
- Klaus K. Wilgenbus
- Company connections
